DAVITA INC.
Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.
CAPITALIZATION 12/31/25
| ($ millions) | Amount | % |
|---|---|---|
| Total debt | 10,273 | 106.8 |
| Stockholders' equity | (651) | -6.8 |
| Total capitalization | 9,622 | 100.0 |
63,800,000 shares outstanding at 31 July 2026 (cover page of the 10-Q filed 4 August 2026).
LONG-TERM DEBT 12/31/25
| ($ millions) | Amount |
|---|---|
| Long-term debt, incl. current maturities | 10,273 |
| Long-term debt, noncurrent | 10,164 |
| Current maturities | 109 |
CAPITAL STOCK 12/31/25
| Common shares authorized | 450,000,000 |
| Common shares issued | 68,549,000 |
| Treasury shares | 0 |
| Par or stated value per share ($) | 0.001 |
| Preferred stock ($ millions) | 0 |
| Outstanding at 7/31/26 | 63,800,000 |
DIVIDENDS DECLARED/PAID
| Fiscal year | Per share $ | Payout % |
|---|---|---|
| 2025 | – | – |
| 2024 | – | – |
| 2023 | – | – |
| 2022 | – | – |
| 2021 | – | – |
HISTORY AND BUSINESS
HISTORY: Incorporated in Delaware. Formerly known as DAVITA HEALTHCARE PARTNERS INC. (to 12 August 2016); TOTAL RENAL CARE HOLDINGS INC (to 28 January 2000).
BUSINESS: Classified by the SEC under Standard Industrial Classification 8090, Services-Misc Health & Allied Services, NEC. Large accelerated filer. Principal executive office: 2000 16Th Street, Denver, CO 80202. Fiscal year ends December 31. For a description of the business, see Item 1 of the latest 10-K.
CONSOLIDATED INCOME ACCOUNT, YEARS ENDED
| ($ millions) | 12/31/25 | 12/31/24 | 12/31/23 |
|---|---|---|---|
| Revenues | 13,643 | 12,816 | 12,140 |
| Depreciation and amortization | 708 | 716 | 736 |
| Operating income | 2,044 | 2,090 | 1,603 |
| Interest expense | 540 | 435 | 374 |
| Income before income taxes | 1,347 | 1,530 | 1,177 |
| Income taxes | 293 | 280 | 220 |
| Net income | 747 | 936 | 692 |
| Earned per share, diluted ($) | 9.84 | 10.73 | 7.42 |
| Dividends per share ($) | – | – | – |
CONSOLIDATED BALANCE SHEET
| ($ millions) | 12/31/25 | 12/31/24 |
|---|---|---|
| Cash and equivalents | 676 | 795 |
| Receivables, net | 2,415 | 2,147 |
| Inventories | 161 | 135 |
| Total current assets | 4,058 | 3,746 |
| Property, plant and equipment, net | 2,813 | 2,941 |
| Goodwill | 7,545 | 7,375 |
| Total assets | 17,480 | 17,285 |
| Total current liabilities | 3,142 | 2,973 |
| Long-term debt | 10,164 | 9,176 |
| Total liabilities | 16,322 | 15,194 |
| Stockholders' equity | (651) | 121 |
| Total liabilities and equity | 17,480 | 17,285 |
TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)
| Fiscal year ended | Revenues | Oper. income | Net income | Net margin % | EPS diluted $ | Div. per share $ | Oper. cash flow | Capital expend. | Free cash flow | Total assets | Total liabilities | Total debt | Stockholders' equity | ROE % | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12/31/25 | 13,643 | 2,044 | 747 | 5.5 | 9.84 | – | 1,886 | 576 | 1,311 | 17,480 | 16,322 | 10,273 | (651) | -114.7 | -15.78 |
| 12/31/24 | 12,816 | 2,090 | 936 | 7.3 | 10.73 | – | 2,022 | 555 | 1,467 | 17,285 | 15,194 | 9,447 | 121 | 773.1 | 77.99 |
| 12/31/23 | 12,140 | 1,603 | 692 | 5.7 | 7.42 | – | 2,059 | 568 | 1,491 | 16,894 | 14,150 | 8,392 | 1,056 | 65.5 | 7.95 |
| 12/31/22 | 11,610 | 1,339 | 560 | 4.8 | 5.85 | – | 1,565 | 603 | 961 | 16,928 | 14,703 | 8,924 | 712 | 78.7 | 12.53 |
| 12/31/21 | 11,619 | 1,797 | 978 | 8.4 | 8.90 | – | 1,931 | 641 | 1,289 | 17,121 | 14,751 | 8,908 | 756 | 129.5 | 11.79 |
| 12/31/20 | 11,551 | 1,695 | 774 | 6.7 | 6.31 | – | 1,979 | 675 | 1,304 | 16,989 | 14,092 | 8,086 | 1,384 | 55.9 | 5.84 |
| 12/31/19 | 11,388 | 1,643 | 811 | 7.1 | 5.27 | – | 2,072 | 767 | 1,306 | 17,311 | 13,812 | 8,108 | 2,133 | 38.0 | 3.80 |
| 12/31/18 | 11,405 | 1,526 | 159 | 1.4 | 0.92 | – | 1,772 | 987 | 785 | 19,110 | 14,077 | 10,102 | 3,703 | 4.3 | 2.73 |
| 12/31/17 | 10,877 | 1,813 | 664 | 6.1 | 3.47 | – | 1,913 | 905 | 1,008 | 18,975 | 13,077 | 9,336 | 4,690 | 14.1 | 1.99 |
| 12/31/16 | 10,707 | 2,030 | 880 | 8.2 | 4.29 | – | 1,972 | 829 | 1,143 | 18,756 | 12,933 | 9,105 | 4,648 | 18.9 | 1.96 |
Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.
REGISTRANT:
DAVITA INC.
CIK 927066 · EIN 51-0354549
PRINCIPAL OFFICE:
2000 16Th Street, Denver, CO 80202
Tel.: 310-536-2668
INCORPORATED:
Delaware
INDUSTRY (SEC SIC CODE):
8090 · Services-Misc Health & Allied Services, NEC
FILER STATUS:
Large accelerated filer
LATEST ANNUAL REPORT:
10-K for period ended 12/31/25, filed 11 February 2026
FORMER NAMES:
DAVITA HEALTHCARE PARTNERS INC.; DAVITA INC; TOTAL RENAL CARE HOLDINGS INC
Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 2/11/26) · 10-K FY2024 (filed 2/13/25) · 10-K FY2023 (filed 2/14/24) · 10-K FY2022 (filed 2/22/23) · 10-K FY2021 (filed 2/11/22) · 10-K FY2020 (filed 2/12/21) · 10-K FY2019 (filed 2/21/20) · 10-K FY2018 (filed 2/22/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.
Data from SEC filings. © 2026 Pathos Investments · pathosinvestments.com · For educational purposes only. Not investment advice.